Literature DB >> 23370948

Purpura fulminans in a patient with mixed connective tissue disease.

Aizuri A Murad1, Michael Jeffers, Anne-Marie Tobin, Maureen Connolly.   

Abstract

A 43-year-old lady was admitted to the intensive care unit with sepsis. She had a history of mixed connective tissue disease, Raynaud's syndrome and hypothyroidism. 2 days later, she developed a purpuric rash on her face and extremities with a livedoid background. Few days later, her distal fingers and toes became gangrenous which then had to be amputated. Laboratory investigations showed that she was coagulopathic and had multiple organ dysfunctions. Antiphospholipid antibodies were negative; however, protein C and antithrombin III levels were low. A skin biopsy showed fibrinoid necrosis in the vessel wall with microthrombi and red-cell extravasation. A diagnosis of purpura fulminans was made.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370948      PMCID: PMC3604251          DOI: 10.1136/bcr-2012-007947

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Fatal pneumococcal septicemia in a patient with a connective tissue disease.

Authors:  A T Guertler; C T Carter
Journal:  J Emerg Med       Date:  1996 Jan-Feb       Impact factor: 1.484

2.  Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment.

Authors:  Simon Fluri; Gregor W Kaczala; Kurt Leibundgut; Lorenzo Alberio
Journal:  Pediatr Emerg Care       Date:  2010-12       Impact factor: 1.454

3.  Purpura fulminans due to Staphylococcus aureus.

Authors:  Gary R Kravitz; David J Dries; Marnie L Peterson; Patrick M Schlievert
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

4.  Purpura fulminans. A cutaneous manifestation of severe protein C deficiency.

Authors:  M J Auletta; J T Headington
Journal:  Arch Dermatol       Date:  1988-09

5.  [A 52-year-old woman with acute shock and purpura fulminans. Pneumococcal sepsis].

Authors:  E Jochum; A Perez-Bouza; S Baumanns; J vom Dahl; U Janssen
Journal:  Internist (Berl)       Date:  2008-06       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.